对于肌肉骨感染管理而言,菌体方法是否是一种传统治疗的替代方案?
Jörg Eschweiler1,2,3, Christian Fischer1, Filippo Migliorini2,4,5
1Department of Trauma and Reconstructive Surgery, BG Klinikum Bergmannstrost Halle, 06112 Halle (Saale), Germany.
Life (Basel, Switzerland)
|October 29, 2025
概括
抗微生物耐药性需要新的治疗方法,如细菌体 (菌根体) 治疗. 菌体疗法为感染提供了潜在的最后手段,需要进一步研究以进行常规医疗使用.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 抗菌素耐药性 (AMR) 构成了全球健康的重大威胁.
- 越来越多的细菌对抗生素的耐药性推动了对替代疗法的需求.
- 菌体 (菌体) 疗法正在成为一个有希望的替代治疗方法.
研究的目的:
- 审查案例并讨论菌体治疗的发展.
- 检查临床实践中菌体治疗的伦理和法律方面的考虑.
- 探索菌体产品对治疗选择有限的患者的优势.
主要方法:
- 对案例和临床实践的文献综述.
- 对围绕菌体治疗的伦理和法律框架的分析.
- 探索基于菌体的治疗方法的潜在好处和挑战.
主要成果:
- 菌体疗法对多药耐药性感染提供了一个可行的选择.
- 临床整合需要考虑道德和法律方面的考虑.
- 进一步的临床研究对于标准化菌体治疗至关重要.
结论:
- 菌体治疗作为对细菌感染的医疗治疗具有显著的潜力.
- 合法化和标准化对于建立菌体治疗作为常规医疗干预至关重要.
- 菌体疗法可以在打击全球抗菌素耐药性方面发挥关键作用.
更多相关视频
相关概念视频
Lytic Cycle of Bacteriophages
77.4K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.4K
DNA Bacteriophages
790
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
790
Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928
Lysogenic Cycle of Bacteriophages
67.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.3K
Biological Methods for Microbial Control
776
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
776
CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K


